Abiomed

Abiomed, Inc.
FormerlyApplied Biomedical Corporation (at founding)
Company typeSubsidiary
Nasdaq: ABMD
IndustryMedical devices
Founded1981; 43 years ago (1981)
FounderDavid Lederman
HeadquartersDanvers, Massachusetts, U.S.
Key people
  • Andrew Greenfield (president)
  • Thorsten Siess (EVP and CTO)
  • Chuck Simonton (EVP and CMO)
ProductsCardiovascular medical implant devices
RevenueIncrease US$1.032 billion (2022)
Decrease US$140.7 million (2022)
Decrease US$136.5 million (2022)
Total assetsDecrease US$976.5 million (2022)
Total equityIncrease US$1.503 billion (2022)
Number of employees
2,003 (2022)
ParentJohnson & Johnson (2022–present)
Websiteabiomed.com
Footnotes / references
[1]

Abiomed, Inc. is a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment.[2] Abiomed develops and manufactures temporary external and implantable mechanical circulatory support devices. The company is headquartered in Danvers, Massachusetts with additional offices in Woburn, Baltimore, Berlin, Aachen, and Tokyo.

Andrew Greenfield is President of the company, with Dr. Thorsten Siess as Executive Vice President and Chief Technology Officer and Dr. Chuck Simonton as Executive Vice President and Chief Medical Officer.[2] According to Bloomberg, the company "engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients".[3]

As of 2022, the company had secured five FDA approvals and 1,408 patents with 1,416 pending.[4] For fiscal year 2022, Abiomed reported $1.032 billion in revenue and reported diluted earnings per share was $2.98 for the year.[1]

On December 22, 2022, Johnson & Johnson completed the acquisition of Abiomed.[5]

  1. ^ a b "US SEC: 2022 Form 10-K ABIOMED, Inc". U.S. Securities and Exchange Commission. 31 March 2022. Retrieved 6 September 2022.
  2. ^ a b Whooley, Sean (22 December 2022). "Johnson & Johnson completes $16.6B Abiomed acquisition". MassDevice. WTWH Media.
  3. ^ "Stocks". Bloomberg News.
  4. ^ "FY 2022 Annual Report". Abiomded. Retrieved 30 September 2022.
  5. ^ "Johnson & Johnson Completes Acquisition of Abiomed". abiomed.com. 2022-12-22.